Business Wire Feed
Ibex Expands U.S. Footprint with HNL Lab Medicine Partnership to Deploy Clinical-Grade AI to Support Cancer Diagnostics
HNL Lab Medicine to integrate Ibex’s AI-powered solution for prostate cancer, building on its existing digital pathology foundation to support high-precision diagnosticsBOSTON & ALLENTOWN, Pa.--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, more...
Periodic Paralysis Association Marks World Periodic Paralysis Day on March 23, Urging Faster Diagnosis and First-Ever Dedicated Research Funding
Global initiative highlights decades-long diagnostic delays and calls for U.S. policy action to improve care, access, and support for rare disease communityCHICAGO--(BUSINESS WIRE)--#ChronicIllness--The Periodic Paralysis Association (PPA) today announced the 2nd annual World Periodic Paralysis more...
CORRECTING and REPLACING PHOTO Lumifi Announces Agreement with Vizient to Strengthen Cybersecurity for Healthcare Organizations
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Please replace the photo for release dated February 18, 2026 with the accompanying corrected photo. The release reads: LUMIFI ANNOUNCES AGREEMENT WITH VIZIENT TO STRENGTHEN CYBERSECURITY FOR HEALTHCARE ORGANIZATIONS Lumifi, a leading provider more...
C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s Disease
ST. LOUIS--(BUSINESS WIRE)--#ADPD2026--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset (Evoke/Evoke+), reflecting ongoing more...
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
Achievement marks advancement of novel obesity target identified through Convergence™ AI platformEMERYVILLE, Calif.--(BUSINESS WIRE)--Fauna Bio, a biotechnology company pioneering the use of extreme mammal biology and comparative genomics to discover novel therapeutic targets, today announced more...
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare DiseaseALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology more...
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Primary endpoint met in Phase 3 TALAPRO-3 study demonstrating a statistically significant and clinically meaningful reduction in risk of disease progression or death in HRR gene-mutated metastatic hormone sensitive prostate cancer Consistent rPFS efficacy benefit more...
BIOQuébec BUDGET 2026–2027: Key Directions on Innovation and Life Sciences and Health Technologies Maintained
LAVAL, Quebec--(BUSINESS WIRE)--BIOQuébec, the association representing the life sciences and health technologies (LSHT) industry, notes that the government is exercising caution by maintaining its direction for these strategic sectors. The 2026–2027 budget is in line more...
INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031
BOSTON & STAFFORDSHIRE, England--(BUSINESS WIRE)--Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). (Q)SAR more...
UK-First AI Case-Finding Pathway Launched to Improve Early Detection of Oesophageal and Gastric Cancer
LONDON--(BUSINESS WIRE)--A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection of Oesophageal and stomach cancers, some of the hardest cancers to diagnose early and among those more...
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
MARSEILLE, France--(BUSINESS WIRE)--#Biotech--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Thursday, March 26, 2026 at 2 p.m. CET more...
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
Expanded label for once-yearly parasiticide treatment for dogs now includes Haemaphysalis longicornis (Asian longhorned tick) and Amblyomma maculatum (Gulf Coast tick) for 12 monthsRAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the more...
Clarion Partners Acquires The Grand at Spokane, a Newly Delivered Luxury Senior Living Community in Washington State
Franklin Templeton specialty investment manager continues its push into commercial real estate investment in the healthcare sectorSAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton, a global investment leader and its specialist investment manager, Clarion Partners, today announced that more...
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced an oral presentation and multiple more...
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today announced that three abstracts will be presented at the 2026 more...
NationsBenefits Reimagines Dental Health with New Fintech Integrated Engagement and AI-Driven Benefit Ecosystem
The first-of-its-kind integration targets the 18% claim denial rate and manual workflows currently straining the $150 billion U.S. dental market.PLANTATION, Fla.--(BUSINESS WIRE)--#NationsBenefits--NationsBenefits®, the leading healthcare fintech and benefits platform, is removing the systemic silos of more...
Ethisphere Names Henry Schein as One of the 2026 World’s Most Ethical Companies® for 15th Consecutive Year
20th annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programsMELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, more...
Ecolab Named One of the World’s Most Ethical Companies for 20th Consecutive Year
Ecolab is just one of six organizations recognized each year since the award’s inceptionST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc., a global leader in water, hygiene and infection prevention solutions and services that protect people and the more...
Ethisphere Names Premier as One of the 2026 World’s Most Ethical Companies® for 19th Consecutive Year
20th annual recognition honors organizations committed to business integrity through robust ethics, compliance and governance programsCHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc., a leading technology-driven healthcare improvement company, has been recognized as one of the 2026 World’s Most more...
ProImmune and the Roslin Institute Collaborate to Advance Animal Health Science
Partnership will validate high quality, species-specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseasesOXFORD, England & EDINBURGH, Scotland--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, more...
Inocras and Broad Institute Researchers Will Release Novel Insights From TCGA Cancer Whole-Genome Analysis at AACR Annual Meeting 2026, Empowering a New Era of Precision Oncology
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology.SAN more...
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding China, Hong Kong, Taiwan, Macau, and Republic of Korea Samsung more...
Truffle Capital Unveils the First Edition of the Truffle MedTech 10
PARIS--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first more...
Renowned Radiosurgery Provider Fully Transitions to ZAP-X® Gyroscopic Radiosurgery® Platform, Marking New Era of Advanced Cranial Radiosurgery
Miami Neuroscience Center Successfully Migrates from Legacy Cobalt-Based Technology to Modern Vault-Free, Cobalt-Free Cranial Radiosurgery DeliverySAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the Miami more...
WELL Health Subsidiary WELLSTAR Expands National Billing Platform with Two Strategic Acquisitions, Now Serving Six Provinces
WELLSTAR has completed the acquisition of two medical billing assets: PatientSERV is Ontario’s leading uninsured and third‑party medical billing platform; Lambert Médico Factures is one of Québec’s most established medical billing providers. These acquisitions significantly more...